Top

News

Al-Shifa has provided the trial site for the phase III clinical trials of COVID-19 vaccine

Continuing its tradition of serving people in times of calamity like in 2005 earthquake and 2011 floods, Alshifa once again has risen to these difficult times. Al-Shifa has provided the trial site for the phase III clinical trials of COVID-19 vaccine, ZF2001 under the complete sponsorship of Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.

Corona virus has caused 3,123,249 deaths globally, and Al-Shifa is doing its part to fight the pandemic by providing a clinical trial site for covid-19 vaccine.

We continue to serve the nation as COVID cases rise. Stay home, stay safe